Published in Women's Health Weekly, December 26th, 2002
A. Lukanova and colleague at the International Agency for Cancer Research, Lyon, France, wrote: "Insulin-like growth factor (IGF)-1, a mitogenic and antiapoptotic peptide, has been implicated in the development of several cancers. We hypothesized that high circulating IGF-1 concentrations may be associated with an increased risk of ovarian cancer. A case-control study was nested within three prospective cohorts in New York (USA), Umea (Sweden), and Milan (Italy)."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.